Dicerna Pharmaceuticals, Inc. Analytics - Traffic, Statistics and Competitor Tracking


Dicerna Pharmaceuticals, Inc. Website Screenshot

http://www.dicerna.com

Dicerna Pharmaceuticals, Inc. Company Intro

Dicerna Pharmaceuticals, Inc., is a biopharmaceutical company using ribonucleic acid interference (RNAi) to develop medicines that silence genes that cause disease.

Industry

Healthcare

Dicerna Pharmaceuticals, Inc. Headquaters

33 Hayden Avenue
Lexington,02421
United States


Dicerna Pharmaceuticals, Inc. Share price

22 Oct 2020 01:30 GMT

$19.20

0.08 (0.42 %)


Dicerna Pharmaceuticals, Inc. Market cap

$1.418 B


WMC RANKING

2020

Dicerna Pharmaceuticals, Inc. # 61

Biotechnology



Latest Dicerna Pharmaceuticals, Inc. News

News 22 Oct 2020

Liver Diseases Therapeutics Market 2020 Emergent ...

The Liver Diseases Therapeutics Market report begins with a basic overview of the ... Inc., Protagonist Therapeutics, Inc., Dicerna Pharmaceuticals, Inc., Endo ...

News 22 Oct 2020

Global Liver Fibrosis Drug Market 2020 Size Share Upcoming ...

... Squibb Company, Celgene Corporation, Dicerna Pharmaceuticals Inc., Digna ... Ltd, Dr. Falk Pharma GmbH, LG Life Science LTD., Nitto Denko Corporati ...

News 22 Oct 2020

High Mobility Group Protein B1 Market Future Scope (2020-2027) | Competitors Analysis and Growth Factors – Ribomic Inc, Cantex Pharmaceuticals Inc, Affibody AB

Ribomic Inc, Cantex Pharmaceuticals Inc, Affibody AB, Dicerna Pharmaceuticals Inc, Evec Inc. The High Mobility Group Protein B1 report uttered an entire view ...

WMC Market Score


WMC Market to Revenue Score


Revenue Total Social Followers Total Social Posts Search Volume Digital Footprint Size Digital change (New Pages) WMC Market Score
Dicerna Pharmaceuticals, Inc. 0.43 1.90 6.54 0 0 0 6.31
Alexion Pharmaceuticals, Inc. 100 13.19 100 19 0 0 98.79
Vertex Pharmaceuticals Incorporated 97.58 100 4.12 30 0 0 100
3SBio Inc. 96.05 0 0 4 0 0 3.02
Incyte Corporation 40.27 14.26 7.26 100 0 0 90.93

Dicerna Pharmaceuticals, Inc. Market Financials


Revenue, Expenses, Profit


Company Revenue Expense Profit Market Cap WMC Sector Score
Dicerna Pharmaceuticals, Inc. $23,904 $152,090 $-120,459 $1.418B 61
Alexion Pharmaceuticals, Inc. $5,536,800 $2,523,000 $846,100 $25.904B 1
Vertex Pharmaceuticals Incorporated $5,402,685 $2,634,428 $2,080,775 $55.058B 2
3SBio Inc. ¥5,318,091 ¥3,085,221 ¥973,717 ¥19.953B 3
Incyte Corporation $2,229,409 $1,622,822 $446,906 $19.377B 4

Market Analytics


Company Search vs Top 4 Industry Competitors



Total Dicerna Pharmaceuticals, Inc. Social Followers vs Top 4 Industry Competitors



Dicerna Pharmaceuticals, Inc. Post vs Top 4 Industry Competitors